Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Rapt Therapeutics Inc (NQ: RAPT ) 3.340 +0.220 (+7.05%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 182,097 Open 3.190 Bid (Size) 3.210 (1) Ask (Size) 3.410 (5) Prev. Close 3.120 Today's Range 3.180 - 3.360 52wk Range 2.610 - 27.35 Shares Outstanding 34,358,152 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Monday's After-Market Session June 03, 2024 Via Benzinga Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month May 21, 2024 Via Benzinga Performance YTD -86.25% -86.25% 1 Month +9.51% +9.51% 3 Month -58.77% -58.77% 6 Month -86.79% -86.79% 1 Year -85.20% -85.20% More News Read More INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against RAPT Therapeutics, Inc. and Encourages Investors to Contact the Firm May 09, 2024 From Schall Law Via GlobeNewswire What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday? May 09, 2024 Via Benzinga Exposures Product Safety RAPT Therapeutics: Q4 Earnings Insights March 07, 2024 Via Benzinga Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session May 09, 2024 Via Benzinga RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q1 2024 May 09, 2024 Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Intraday Session May 09, 2024 Via Benzinga RAPT Therapeutics Reports First Quarter 2024 Financial Results May 09, 2024 From RAPT Therapeutics, Inc. Via GlobeNewswire RAPT Therapeutics Announces Promising Results from Phase 2 Trial of Tivumecirnon in Combination with Anti-PD-1 Immunotherapy in CPI-Experienced Head and Neck Cancer Patients April 09, 2024 From RAPT Therapeutics, Inc. Via GlobeNewswire 3 Biotech Stocks to Dump Before They Go to Zero April 09, 2024 Via InvestorPlace RAPT ALERT: Bragar Eagel & Squire, P.C. is Investigating RAPT Therapeutics, Inc. on Behalf of RAPT Stockholders and Encourages Investors to Contact the Firm March 11, 2024 From Bragar Eagel & Squire Via GlobeNewswire RAPT Stock Earnings: RAPT Therapeutics Beats EPS for Q4 2023 March 07, 2024 Via InvestorPlace RAPT Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results March 07, 2024 From RAPT Therapeutics, Inc. Via GlobeNewswire RAPT Therapeutics Announces Multiple Late-Breaking Presentations at the Upcoming American Association for Cancer Research (AACR) Annual Meeting March 05, 2024 From RAPT Therapeutics, Inc. Via GlobeNewswire RAPT Therapeutics, Inc. (RAPT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings February 26, 2024 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire Rivian Automotive Reports Q4 Loss, Joins Etsy, Lucid Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session February 22, 2024 Via Benzinga What's Going On With RAPT Therapeutics Stock On Wednesday? February 21, 2024 Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Wednesday's Intraday Session February 21, 2024 Via Benzinga Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session February 21, 2024 Via Benzinga Stocks Slip Ahead Of Fed Minutes, Nvidia Earnings February 21, 2024 Via Talk Markets Topics Economy Stocks Exposures Interest Rates US Equities Crude Oil Moves Lower; Summit Therapeutics Shares Plummet February 20, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Fluor Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session February 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session February 20, 2024 Via Benzinga Why Is Inflammatory Disease/Oncology-Focused RAPT Therapeutics Shares Tumbling Today? February 20, 2024 Via Benzinga Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.